ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age [clear]
Topic Area [clear]
Experience
Course Format [clear]
SIG
Instructional Level
Presenter(s): Bethany L Kusek , MA, CCC-SLP; Andrea Elise Kremeier, MS, CCC-SLP, CBIS; Jett Mickelsen Stenson, MS, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: In the era of COVID-19, clinicians in health care settings have faced challenges in the evaluation and treatment of a new patient population - those who have had COVID-19 - requiring us to reframe our current treatment techniques. This session focuses on reinventing the SLP's approach to treatment of respiratory activity tolerance for motor speech.
Credit(s): PDHs: 4.5, ASHA CEUs*: 0.45
Summary: Meta-therapy is an integral pillar of clinical practice; however, the lack of formal training in this area often makes the concept and application of meta-therapy elusive to clinicians. The goal of this SIG 3 activity is to disseminate how meta-therapy can be effectively utilized in the clinical domains of voice disorders, fluency, dysphagia, and cognitive communication and aphasia.
Presenter(s): Julie A G Stierwalt, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Principles of motor learning (PML) are guidelines developed for the purpose of training motor execution of movement. Initially designed for training in the limbs, the methods have been adapted for use with the oral motor system. This course reviews how PML can be employed in training protocols targeting speech production.
Presenter(s): Rene L Utianski, PhD, CCC-SLP, BC-ANCDS; Kristie A Spencer, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Motor speech disorders occur secondary to a wide variety of progressive neurological disorders. This course discusses strategies for the speaker, listener, and environment that clinicians can consider for managing progressive motor speech disorders. Presenters discuss management strategies in the context of concomitant decline of cognitive-linguistic and motoric function from neurodegenerative processes.